P ersistent pulm onary hypertension o f the new born (PPH N ) is a syndrome w ith estimated incidence o f 1:1500 live births. It is characterized by severe hypoxemia attributed to failure o f pulm onary vascular resistance to decrease below that o f systemic pressure after birth, resulting in right to left shunt o f the blood at the intra-as well as extra-pulm onary level through the ductus arteriosus and/or foramen ovale. W hile more com m on in term infants, P P H N is observed rarely in extremely low birth weight infants. T he use o f inhaled nitric oxide (iN O ) in prem ature infants in the treatm ent o f P P H N has remained controversial.1,2 We report a case o f a newborn o f 23-weeks gestation that experienced typical P P H N and responded successfully to iN O .
Case Report
T he 664-gram, male was born by a spontaneous vaginal delivery at 23-weeks gestation confirmed by antenatal ultrasound and a last menstrual period to a 25-year-old primigravida mother. T he pregnancy was uneventful apart from one episode o f urinary tract infection, which was treated successfully. T he m other completed one course o f dexamethasone prior to delivery. T he baby required intubation in the delivery room for inadequate breathing and bradycardia. His Apgar scores were 2 ,5 , and 6 at the first, fifth, and tenth minutes, respectively. Surfactant (Survanta) was given in the delivery room. T he chest x-ray was compatible with respiratory disease. Two more doses o f surfactant were given. Despite maximum ventilatory and hemodynamic support, systemic oxygenation was compromised and differential cyanosis was noted w ith a more than 10% difference between pre-and post-ductal oxygen saturation. Echocardiography confirmed the diagnosis o f P P H N with pulm onary pressure exceeding systemic levels, and right to left shunting o f the blood through the patent foramen ovale (Figure 1 ). High frequency oscillatory ventilation (HFOV) was started but there was no improvement. His oxygenation index (OI) and the alveolar arterial gradient (a/A) during H F O V were 40.4 and 0.0534, respectively.
Inhaled nitric oxide was decreased gradually to discontinuation over five days. N o acute toxicity during iN O therapy was observed.
U ltrasound of the head showed grade 2 intraventricular Ann Saudi M ed 24(1) January-February 2 0 0 4 www.kfshrc.edu.sa/annals hemorrhages that resolved with time. Apart from episodes o f feeding intolerance and mild chronic lung disease during his early hospital course, the baby did well and was discharged hom e in good health at 36 weeks corrected age. There were no neurological deficits observed during his outpatient visits.
Discussion
There is an assumption that preterm infants lack sufficient arteriolar musculature to maintain a prolonged elevated pulm onary vascular resistance after birth. This report shows that extremely low birth weight infants are at risk o f developing PPH N . T he baby's response to iN O confirms that midgestation pulm onary vasculature is responsive to iN O . Reports available in the literature described larger premature infants with evidence o f perinatal asphyxia.3,4 In this report, the infant had no evidence o f perinatal asphyxia, but his P P H N was attributed to lung disease. T he infant received an early dose o f surfactant as prophylaxis in the delivery room, which was repeated twice. Despite the surfactant therapy, the infant developed PPH N , which was not controlled by HFOV. H e showed a dramatic response to iN O with clear reverse o f the shunt as evidenced by the echocardiogram.
These extremely premature infants are at the ultimate edge o f embryological viability and, by definition o f pulm onary hypertension, their lungs have major structural and functional defects. In the hum an fetus, the preacinar arteries and those at the terminal bronchiolar level are muscular, and continue to increase in thickness throughout the fetal life, while the intraacinar arteries (those accompanying respiratory bronchioles) are partially muscular (surrounded by spiral muscles) or non-muscular. At 23-weeks gestation, the main respiratory unit is the respiratory bronchioles accompanied by a partial yet developing muscular layer.5,6 T he surfactant-producing unit is virtually immature, which may explain the poor and partial response to surfactant therapy in the 23-25 weeks premature infants. 6 Kinsella et al7 demonstrated in some experimental models o f hyaline membrane disease that pulmonary vascular resistance fails to decrease in response to mechanical ventilation alone and surfactant therapy does not change the direction or the magnitude o f the systemic to pulm onary shunting across the patent ductus arteriosus. It was shown that endogenous nitric oxide production could alter the basal pulm onary vascular tone very early in the ovine fetus and contribute to increases in pulm onary blood flow in extremely premature infants. They also observed deterioration o f gas exchange despite a good initial response to exogenous surfactant while there was a satisfactory response to exogenous iN O . Skimming et al8 described similar observations. Preliminary studies in hum an premature infants, with severe hypoxemic respiratory failure, support the role o f low does o f iN O as adjuvant therapy, which has led to significant improvement in oxygenation. 7, 8 Ochikubo et al9 assessed the echocardiographic findings o f 25 newborn infants older than 32 weeks gestation who 
